Electromed Inc (ELMD)

Electromed, Inc. is a healthcare equipment company focused on airway clearance therapy and related products based on high frequency chest wall oscillation (HFCWO). Its portfolio includes the SmartVest airway clearance system for patients with impaired pulmonary function, such as those with bronchiectasis, cystic fibrosis, and certain neuromuscular or post-surgical conditions. The company also offers the SmartVest SQL System, the SmartVest Clearway System, and SmartVest Connect, a wireless platform designed to support data sharing between physicians and patients and help monitor therapy performance. In addition, Electromed supplies single-patient-use SmartVest and SmartVest Wrap products for acute care settings. The company sells its products to physicians, healthcare providers, and patients in the United States and international markets. Electromed was incorporated in 1992 and is headquartered in New Prague, Minnesota.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-ELMD
$27.94
0.8% Upside
Fair
$48.50
75.0% Upside
Bargain
Great
0.0%
November 10, 2026
20.1x
4.2x
3.1x
230.7 M
206.7 M
0.1%
82.9%
14.4
74.4%
Valuation • Fair Value

Electromed Inc (NYSE-ELMD) Fair Value by Valuation Model

Review the available estimates for Electromed Inc (NYSE-ELMD), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$27.94

Estimated upside of 0.8% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$29.43

Discounted cash flow valuation reference.

Ben Graham Formula Value

$14.99

Classic Ben Graham valuation formula reference.

EPV Fair Value

$18.23

Earnings power value estimate.

Comps Fair Value

$28.07

Comparable-company valuation reference.

Analyst Price Target

$48.50

Analysts imply upside of 75.0%.

How to read these valuation models

Use the 7 available valuation references for Electromed Inc (NYSE-ELMD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Electromed Inc (NYSE-ELMD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

73.776 M

Current operating scale indicator.

Revenue Forecast

83.15 M

Forward revenue estimate.

EBITDA

14.807 M

Current operating profitability reference.

EBITDA Forecast

21.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Electromed Inc (NYSE-ELMD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Electromed Inc (NYSE-ELMD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.09

Intermediate zone that deserves monitoring.

Altman Z-Score

14.4

Relatively strong balance-sheet zone.

FCF / Net Income

74.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Electromed Inc (NYSE-ELMD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Electromed Inc (NYSE-ELMD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Electromed Inc (NYSE-ELMD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Electromed Inc (NYSE-ELMD) Stock Forecast & Technical Outlook

Review Electromed Inc (NYSE-ELMD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Electromed Inc (NYSE-ELMD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Electromed Inc (NYSE-ELMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Electromed Inc (NYSE-ELMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Electromed Inc (NYSE-ELMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Electromed Inc (NYSE-ELMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Electromed Inc (NYSE-ELMD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Electromed Inc (NYSE-ELMD) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ Fast Investor Answers

Electromed Inc (NYSE-ELMD) Stock FAQ

Data-supported answers about Electromed Inc (NYSE-ELMD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$27.94
Estimated upside 0.8%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$48.50
Implied upside 75.0%
Financial Health
Great
Current financial-health read

The current fair value estimate for Electromed Inc (NYSE-ELMD) is $27.94. This implies an estimated upside of 0.8% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for Electromed Inc (NYSE-ELMD) is $48.50. The analyst target implies estimated upside of 75.0%.

The current financial health read for Electromed Inc (NYSE-ELMD) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Electromed Inc (NYSE-ELMD) is November 10, 2026.

The latest available data indicates no current dividend yield for Electromed Inc (NYSE-ELMD).

The current P/E ratio listed for Electromed Inc (NYSE-ELMD) is 20.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Electromed Inc is 230.7 M.

The current enterprise value listed for Electromed Inc is 206.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Electromed Inc is NYSE-ELMD, and the stock is listed on NYSE.

Electromed Inc (NYSE-ELMD) is listed on NYSE.

The current debt-to-total-capital ratio listed for Electromed Inc is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Electromed Inc is 82.9%. Free float helps investors understand how much of the share base is available for public trading.